LENSRXLAB Introduces Groundbreaking Vision Benefits Platform Catered to Diabetic Individuals

Revolutionary Initiative Offers Specialized Eyewear Solutions and Support for Diabetes Management

PHILADELPHIA--(BUSINESS WIRE)--
LENSRXLAB, a leading provider of diabetic, safety, and dress eyewear, announces the launch of its Supplemental Vision Benefits Platform for Diabetics, aiming to revolutionize vision care. Founded by a Military Submarine Force Veteran and Optometrist, the platform offers an all-in-one prescription diabetic eyewear package, now available for Hospitals, Medical Clinics, Health Insurance Companies, Corporate Employers, Military/Veteran Organizations, Diabetic Care Centers, Health Programs, and more.

The platform is accessible 24/7 throughout Pennsylvania and across the United States, including Washington DC, Puerto Rico, American Samoa, Guam, Northern Mariana Islands, and the United States Virgin Islands.

"We are thrilled to extend our Supplemental Vision Benefits Platform to a wide range of institutions and organizations throughout the US and globally," said Anthony B. Miles, CEO of LENSRXLAB and US Navy Trident Nuclear Submarine Veteran. "With our easy-to-use platform, employers and institutions can ensure that their employees, patients, service members, veterans, and beneficiaries receive the vision care they need to thrive in their professional and personal lives."

"Our all-in-one diabetic packages represent a holistic approach to vision care, addressing not just visual needs but also prioritizing the medical aspects of diabetic eye health. By integrating advanced technologies and medical-grade materials, we aim to provide comprehensive solutions that promote eye wellness and enhance quality of life for individuals, men, women, and children managing diabetes," said Dr. Chelise Firmin, Optometrist, Founder of LENSRXLAB.

LENSRXLAB's Supplemental Vision Benefits Platform for Diabetics offers a comprehensive eyewear solution designed to enhance employee wellness and productivity. Key platform benefits include:

- LENSRXLAB founders’ subsidy: Organizations and individuals are eligible for a 40% subsidy on prescription diabetic eyewear.

- Zero cost enrollment: Organizations pay nothing to enroll in LENSRXLAB's Supplemental Vision and Health Benefits Platform.

- No contractual obligations: Organizations can assess platform benefits without long-term commitments.

- Support for veterans: Enrolling organizations actively support a Service-Disabled Veteran Owned Small Business, contributing to supplier diversity and creating job opportunities for low-income and formerly incarcerated individuals.

Aligned with fostering economic growth and supporting workforce development, LENSRXLAB's platform aims to promote a healthy community. By offering comprehensive vision benefits, institutions can attract top talent, improve satisfaction, and contribute to their region's success.

For institutions interested in learning more about LENSRXLAB's Supplemental Vision Benefits Platform, visit www.diavistalenstech.com or contact Jennifer K. Marin at [email protected].

About LENSRXLAB:

LENSRXLAB Supplemental Vision and Health Benefits Platform provides affordable eye health solutions for institutions in the United States, Puerto Rico, American Samoa, Guam, Northern Mariana Islands, and the United States Virgin Islands. With a mission to serve over 450,000 patients annually, LENSRXLAB aims to benefit over 1,000,000 individuals at risk or diagnosed with diabetes through its innovative DiaVista high-performance lens technology powered by Nirtech®. Led by Anthony B. Miles, Dr. Chelise Firmin, and Jennifer K. Marin, LENSRXLAB is a distinguished Black American Service-Disabled Veteran-Owned Ophthalmic Goods Manufacturing & Merchant Wholesaler Small Business Enterprise.

For more information, visit www.diavistalenstech.com

src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20240424622883r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />

View source version on businesswire.com: https://www.businesswire.com/news/home/20240424622883/en/

Jennifer K. Marin
[email protected]

Source: LENSRXLAB